Kronos Bio Long Term Debt

Kronos Bio (KRON) currently reports a long-term debt of $20M as of March 2025. That compares with $24M in the prior-year period — down 16.4% year over year. Use the charts on this page to explore Kronos Bio's long-term debt history and peer comparisons.

Kronos Bio's long-term debt decreased from $24M to $20M — a 16.4% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kronos Bio reported $20M in long-term debt as of March 2025. That compares with $24M in the prior-year period — down 16.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kronos Bio, and consider following KRON for alerts when major investors trade the stock.

Kronos Bio is classified in the Healthcare sector. On long-term debt, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRON with unrelated industries.